Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 933-945

  Swanson, C J ^a   Heath, S ^a   Stratford, T R ^a   Kelley, A E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Dopamine receptors; Feeding behavior; Locomotor activity; Nucleus accumbens; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE; QUINPIROLE; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REARING;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; FEEDING BEHAVIOR; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANCE P;

EID: 0031406582     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00043-9     Document Type: Article

References (82)

1. Ahlenius S. Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity. Evidence for the functional importance of somatodendritic autoreceptors Naunyn-Schmiedeberg Arch. Pharmacol. 345:1992;6-522.
2. Ahlenius S., Salmi P. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH0DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol. 260:1994;177-181.
3. Alheid G. F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders. The striatopallidal, amygdaloid, and corticopetal components of substantia innominata Neuroscience. 27:1988;1-39.
4. Andén N.-E. Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens. Adv. Biochem. Psychopharmacol. 16:1977;385-389.
5. Annett L. E., McGregor A., Robbins T. W. The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat. Behav. Brain Res. 31:1989;231-242.
6. Bardo M. T., Bowling S. L., Robinet P. M., Rowlett J. K., Lacy M., Mattingly B. A. Role of dopamine D-1 and D-2 receptors in novelty-maintained place-preference. Exp. Clin. Psychopharmacol. 1:1993;101-109.
7. Bardo M. T., Hammer R. P. Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens. Resistance to differential rearing conditions Neuroscience. 45:1991;281-290.
8. Berod A., Hartman B. K., Pujol J. F. Importance of fixation in immunohistochemistry. Use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase J. Histochem. Cytochem. 29:1981;844-850.
9. Bordi F., Carr K. D., Meller E. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens. Brain Res. 489:1989;205-215.
10. Braun A. R., Chase T. N. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behavior. Eur. J. Pharmacol. 131:1986;301-306.
11. Breese G. R., Duncan G. E., Napier T. C., Bondy S. C., Iorio L. C., Mueller R. A. 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D-1 and D-2 dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240:1987;167-176.
12. Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon J., Christie M., Machida C. A., Neve K. A., Civelli O. Cloning and expression of rat D-2 dopamine receptor. Nature. 336:1988;347-348.
13. Caine S., Heinrichs S. C., Coffin V., Koob G. F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration. Brain Res. 692:1995;47-56.
14. Camacho-Ochoa M., Walker E. L., Evans D. L., Piercey M. F. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist. Neurosci. Lett. 196:1995;97-100.
15. Carr G. D., White N. Effects of systemic and intracranial amphetamine injections on behavior in the open field. A detailed analysis Pharmacol. Biochem. Behav. 27:1987;113-122.
16. Cools A. R., Jongen-Relo A. L. Role of mesostriatum and nucleus accumbens in stepping induced by apomorphine and dexamphetamine. Brain Res. Bull. 26:1991;909-917.
17. Costall B., Naylor R. J. Apomorphine as an antagonist of the dopamine response from the nucleus accumbens. J. Pharm. Pharmacol. 28:1976;592-595.
18. Delfs J. M., Schreiber L., Kelley A. E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci. 10:1990;303-310.
19. Deutch A. Y., Cameron D. S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
20. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
21. Diaz J., Levesque D., Lammers C. H., Griffon N., Martres M.-P., Schwartz J.-C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65:1995;731-746.
22. Dreher J. K., Jackson D. M. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens in rats. Brain Res. 487:1989;267-277.
23. Essman W. D., McGonigle P., Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology. 112:1993;233-241.
24. Fletcher G. H., Starr M. S. Behavioral evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Eur. J. Pharmacol. 138:1987;407-411.
25. Groenewegen H. J., Berendse H. W., Meredith G. E., Haber S. N., Voorn P., Wolters J. G., Lohman A. H. M. Functional anatomy of the ventral, limbic system-innervated striatum. Willner P., Scheel-Kruger J. The mesolimbic dopamine system. From motivation to action:1991;19-60 John Wiley & Sons, Chichester, England.
26. Heimer L., Zahm D. S., Churchill L., Kalivas P. W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
27. Henry D. J., White F. J. Repeated cocaine administration causes persistent enhancement of D-1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exper. Ther. 258:1991;882-890.
28. Hernandez L., Hoebel B. G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42:1988;1705-1712.
29. Hoffman D. C., Beninger R. J. Selective D-1 and D-2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol. Biochem. Behav. 31:1988;1-8.
30. Horger B. A., Elsworth J. D., Roth R. H. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. J. Neurochem. 65:1995;770-774.
31. Jackson D. M., Anden N.-E., Dahlstrom A. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia. 45:1975;139-149.
32. Jackson D. M., Ross S. B., Lars L.-G. Dopamine D-2 receptor agonist-induced behavioral depression. Critical dependence upon postsynaptic dopamine D-1 function Naunyn-Schmiedeberg Arch. Pharmacol. 340:1989;355-365.
33. Jackson D. M., Westland-Danielsson A. Dopamine receptors. Molecular biology, biochemistry, and behavioral aspects Pharmacol. Ther. 64:1994;291-369.
34. Kebabian J. W., Britton D. R., DeNinno M. P., Perner R., Smith L., Jenner P., Schoenleber R., Williams M. A-77636. A potent and selective dopamine D-1 receptor agonist with antiparkinsonian activity in marmosets Eur. J. Pharmacol. 229:1992;203-209.
35. Kelley A. E., Stinus L. Disappearance of hoarding behavior after 6-hydroxy lesions of the mesolimbic dopamine neurons and its reinstatement with L-Dopa. Behav. Neurosci. 99:1985;531-545.
36. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
37. Maldonado-Irizarry C. S., Kelley A. E. Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat. Behav. Pharmacol. 6:1995;527-539.
38. Maldonado-Irizzary C. S., Swanson C. J., Kelley A. E. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci. 15:1995;6779-6788.
39. Marshall J. F., O'Dell S. J., Navarrete R., Rosenstein A. J. Dopamine high-affinity transport site topography in rat brain. Major differences between dorsal and ventral striatum Neuroscience. 37:1990;11-21.
40. Meyer M. E., Shults J. M. Dopamine D-1 receptor family agonists, SK&F 38393,SK&F 77434, and SK&F 82958 differentially affect locomotor activities in rats. Pharmacol. Biochem. Behav. 46:1993;269-274.
41. Meyer M. E., Van Hartesveldt C., Potter T. J. Locomotor activity following intra-accumbens microinjections of dopamine D-1 agonist SKF 38393 in rats. Synapse. 13:1993;310-314.
42. Mierau J., Schingnitz G. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur. J. Pharmacol. 215:1992;161-170.
43. Mierau J., Schneider F. J., Ensinger H. A., Chio C. L., Lakiness M. E., Huff R. M. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur. J. Pharmacol. 290:1995;29-36.
44. Mogenson G. J., Jones D. L., Yim C. Y. From motivation to action. Functional interface between the limbic system and the motor system Prog. Neurobiol. 14:1980;69-97.
45. Molloy A. G., O'Boyle K. M., Pugh M. T., Waddington J. L. Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol. Biochem. Behav. 25:1986;249-253.
46. Molloy A. G., Waddington J. L. Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SKF 38393 and selectively blocked by the D-1 antagonist SCH 23390. Psychopharmacology. 82:1984;409-410.
47. Nakajima S., Xinhe L., Lau C. L. Synergistic interaction of D-1 and D-2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav. Neurosci. 107:1993;161-165.
48. O'Boyle A. G., Gaitanopoulos D. E., Brenner M., Waddington J. L. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology. 28:1989;401-405.
49. Pennartz C. M. A., Dolleman-Van der Weel M. J., Lopes da Silva F. H. Differential membrane properties and dopamine effects in the shell and core of rat nucleus accumbens studied in vitro. Neurosci. Lett. 136:1992;109-112.
50. Pennartz C. M. A., Dolleman-Van der Weel M. J., Kitai S. T., Lopes da Silva F. H. Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. J. Neurophysiol. 67:1992;1325-1334.
51. Pierce R. C., Kalivas P. W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol Exp. Ther. 275:1995;1019-1029.
52. Pijnenburg A. J. J., Honig W. M. M., Van Rossum J. M. Effects of antagonists upon locomotor stimulation induced by injection of dopamine into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia. 41:1975;175-180.
53. Pilotte N. S., Sharpe L. G., Rountree S. D., Kuhar M. J. Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens. Synapse. 22:1996;87.
54. Plaznik A., Stefanski R., Kostowski W. Interaction between accumbens D-1 and D-2 receptors regulating rat locomotor activity. Psychopharmacology. 99:1989;558-562.
55. Prinssen E. P. M., Balestra W., Bemelmans F. F. J., Cools A. R. Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats. J. Neurosci. 14:1994;1555-1562.
56. Ranaldi R., Beninger R. J. Dopamine D-1 and D-2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. Psychopharmacology. 113:1993;110-118.
57. Ranaldi R., Beninger R. J. The effects of systemic and intracerebral injections of D-1 and D-2 agonists on brain stimulation reward. Brain Res. 651:1994;283-292.
58. Robbins T. W., Cador M., Taylor J. R., Everitt B. J. Limbic-striatal interactions in reward-related processes. Neurosci. Biobehav. Rev. 13:1989;155-162.
59. Rowlett J. K., Mattingly B. A., Bardo M. T. Repeated quinpirole treatment. Locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists Synapse. 20:1995;209-216.
60. Salamone J. D., Steinpreis R. E., McCullough L. D., Smith P., Grebel D., Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology. 104:1991;515-521.
61. Sautel F., Griffon N., Levesque D., Pilon C., Schwartz J. C., Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. NeuroReport. 6:1995;329-332.
62. Self D. W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94.
63. Sokoloff P., Giros B., Martress M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor. Nature. 347:1990;146-151.
64. Sorg B. A., Guminski B. J. M., Hooks M. S., Kalivas P. W. Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell. Mol. Brain Res. 29:1995;381-386.
65. Staton D. M., Solomon P. R. Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol. Psychol. 12:1984;159-162.
66. Stoof J. C., Kebabian J. W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 294:1981;366-368.
67. Sunahara R. K., Guan H. C., O'Dowd B. F., Seeman P., Laurier L. G., Ng G., George S. R., Torchia J., Van T. H., Nizinik H. B. Cloning of the gene for human dopamine D-5 receptor with higher affinity for dopamine than D-1. Nature. 350:1991;614-619.
68. Sunahara R. K., Niznik H. B., Weiner D. M., Stormann T. M., Brann M. R., Kennedy J. L., Gelernter J. E., Rozmahel R., Yang Y. L., Israel Y., Seeman P., O'Dowd B. F. Human dopamine D-1 receptor encoded by an intronless gene on chromosome 5. Nature. 347:1990;80-83.
69. Unterwald E. M., Ho A., Rubenfield J. M., Kreek M. J. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol. Exp. Ther. 270:1994;1387-1397.
70. Van Ree J. M., Wolterink G. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity. Eur. J. Pharmacol. 72:1981;107-111.
71. Van Tol H. H. M., Bunzow J. R., Guan H.-C., Sunahara R. K., Seeman P., Niznik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
72. Voorn P., Gerfen C. R., Groenewegen H. J. The compartmental organization of the ventral striatum of the rat. Immunohistochemical distribution of enkephalin, substance P, dopamine, and calcium binding protein J. Comp. Neurol. 289:1989;189-201.
73. Voorn P., Jorritsma-Byham B., Van Dijk C., Buijs R. M. The dopaminergic innervation of the ventral striatum in the rat. A light- and electron-microscopical study with antibodies against dopamine J. Comp. Neurol. 251:1986;84-99.
74. Walters J. R., Bergstrom D. A., Carlson J. H., Chase T. N., Braun A. R. D-1 dopamine receptor activation required for postsynaptic expression of D-2 agonist effects. Science. 236:1987;719-722.
75. White F. J. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur. J. Pharmacol. 135:1987;101-105.
76. White F. J., Bednarz L. M., Wachtel S. R., Hjorth S., Brooderson R. J. Is stimulation of both D-1 and D-2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol. Biochem. Behav. 30:1988;189-193.
77. White N. M., Packard M. G., Hiroi N. Place conditioning with dopamine D-1 and D-2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology. 103:1991;271-276.
78. Wise R. A., Bozarth M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
79. Woolverton W. L. Effects of a D1 and D2 antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:1986;531-535.
80. Woolverton W. L., Goldberg L. I., Ginos J. Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.
81. Zahm D. S. Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopoamine into the ventral mesencephelon. Brain Res. 552:1991;164-169.
82. Zahm D. S., Brog J. S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.